GlassScriptPhysician profile
Erin E Pettey
NPI 1245677087
$1,374.08
in general payments reported to CMS, 2019-2025
17 companies · $411 in 2025
The $411 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $282 · 2023: $180 · 2024: $323 · 2025: $411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $913.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $913.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $217.44 | 2022-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $207.03 | 2022-2025 | Farxiga, Breztri |
| Novo Nordisk INC | $158.06 | 2021-2025 | Wegovy, Rybelsus, Ozempic |
| Abbvie INC. | $152.87 | 2022-2024 | |
| Dexcom, INC. | $97.46 | 2022-2024 | Dexcom G6 Transmitter |
| Boston Scientific Corporation | $87.02 | 2021 | |
| Inspire Medical Systems, INC. | $84.48 | 2023-2025 | Inspire |
| Glaxosmithkline, LLC. | $59.56 | 2021 | |
| Exact Sciences Corporation | $56.36 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Pfizer INC. | $52.20 | 2024 | |
| Mylan Specialty L.P. | $47.10 | 2024 | Yupelri |
| Medtronic, INC. | $39.14 | 2025 | Inceptiv |
| Chiesi USA, INC. | $35.14 | 2024 | Lamzede |
| Antares Pharma, INC. | $23.71 | 2025 | Xyosted |
| Gilead Sciences, INC. | $23.40 | 2024 | Epclusa |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $18.31 | 2022 | |
| Amgen INC. | $14.80 | 2025 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Pettey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.